Mar 29
|
ICON Public Limited Company (ICLR) Improved by 15% in Q4
|
Mar 25
|
ICON plc Schedules First Quarter 2024 Earnings Conference Call
|
Mar 22
|
ICON (ICLR) Up 7.6% Since Last Earnings Report: Can It Continue?
|
Mar 15
|
Icon PLC (ICLR) Is a Great Choice for 'Trend' Investors, Here's Why
|
Mar 14
|
ICLR vs. DOCS: Which Stock Is the Better Value Option?
|
Mar 14
|
ICON (NASDAQ:ICLR) shareholders have earned a 20% CAGR over the last five years
|
Mar 14
|
Zacks Industry Outlook Highlights Elevance Health, Cencora and ICON
|
Mar 13
|
3 Medical Services Stocks to Buy as Industry Trends Improve
|
Mar 4
|
ICON (ICLR) Gains From Strategic Deals, New Innovations
|
Jan 30
|
ICON plc Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call
|
Jan 27
|
ICON Public Limited Company's (NASDAQ:ICLR) Stock Is Going Strong: Have Financials A Role To Play?
|
Jan 9
|
ICON Issues Financial Guidance for Full Year 2024
|
Jan 8
|
Biotech companies to increase R&D spend but highlight complexity of clinical trials - ICON
|
Jan 5
|
Should You Be Adding ICON (NASDAQ:ICLR) To Your Watchlist Today?
|
Jan 4
|
ICON plc to Present at the 42nd Annual J.P. Morgan Healthcare Conference
|
Dec 18
|
ICON Wins Industry Accolades from TIME Magazine, Forbes and Financial Times in Second Half of 2023
|
Dec 8
|
Reasons to Invest in ICON (ICLR)
|
Dec 7
|
ICON Secures Upgraded Credit Rating from Moody’s Investors Service
|
Nov 8
|
ICON plc to Present at Upcoming Investor Conferences
|
Nov 6
|
Is it Still Worthy to Invest in ICON Public Limited (ICLR)?
|